Conferences  >  Medicine & Healthcare  >  Translational Medicine, Clinical Trials

Virtue Insight

The 9th Annual Pharma Regulatory Summit 2026 congregates foremost global pharmaceutical industry professionals and regulators to share their insights on technologies, approaches, and solutions that will drive innovation and quality for the medicines delivered to patients worldwide. This interactional setting with expert-led regulatory and industry presentations will ensure pharmaceutical industry professionals to develop and apply ingenious solutions in today’s Indian pharma ecosystem.

Phone: [9361957193];     Email: Kavitha@virtueinsight.co.in

Regulatory Affairs, Regulatory Writing, Medical Writing, Publishing, Submissions, scientific writing

Allan Lloyds

The 12th Annual Risk Management and Pharmacovigilance Summit will take place in Berlin on 6–7 May 2026 and will bring together senior leaders from the pharmaceutical and biotechnology industries to discuss key challenges and innovations in drug safety and pharmacovigilance. The event will explore topics such as AI-powered signal detection, regulatory developments, risk management plans, data integrity, and the integration of real-world evidence into pharmacovigilance systems, providing practical insights and networking opportunities for professionals involved in drug safety, regulatory affairs, and patient safety.

Marketing Manager;     Phone: [+421 2 21 021 348];     Email: vladyslava.malenta@alloydsevents.com

pharmacovigilance, drug safety, risk management, regulatory affairs, clinical safety, signal detection, benefit-risk assessment, patient safety, pharmaceutical industry, pharmacovigilance systems

Public Lectures and Outreach,    Pharmacogenomics, Personalized Medicine

European Association for the Study of the Liver (EASL)

The need to understand basic epidemiological concepts cannot be overstated for researchers wanting to make a career in any medical field, including hepatology. This course will give an overview of common and cutting-edge methodologies in clinical epidemiology that will be highly useful for clinicians wanting to develop their capacity to read, interpret, and understand limitations of clinical studies in medical journals. Instead of presenting a clinical case, the course will focus on practical skills needed to understand or design clinical studies and to be able to spot flaws and limitations in their own and other’s research work. In essence, this course will improve the knowledge of applied clinical study design and methodology for the next generation of clinicians and clinical researchers in hepatology.

Hepatology,    Continuing Medical Education (CME)

Kenes Exhibitions

Join us for the 3rd RNA Horizons Conference, taking place September 16–18, 2026, in Munich, Germany. This premier event brings together scientists, clinicians, and biotech innovators to explore the latest advancements in RNA therapeutics, spanning established modalities as well as emerging areas such as ASOs and RNA structure–based therapies. Discussions will cover key trends, including pipeline diversification, enhanced RNA modalities, AI integration, and improved delivery technologies. Notably, the conference will focus on translating discoveries into viable therapies, with insights into commercialization and market access.

Phone: [972 747457435];     Email: skrein@kenes-exhibitions.com

RNA therapeutics, RNA biology, RNA medicine, RNA delivery, antisense oligonucleotides, self-amplifying RNA, RNA-based therapy, cancer research, oncology innovation, RNA stability, clinical translation, biotechnology, life sciences, European biotech, Horizon Europe, CANCERNA consortium, Hadassah Cancer Research Institute, RNA Horizons, RNA conference Europe, Munich 2026, RNA innovation, European research collaboration

Biotechnology,    Pharmacology and Drug Development